baber/WOPTO huggingface dataset:
Patent FI-834672-A0 (FI)
Inventor: HENSLEE WALTER WARREN
IPC: C04B28/34
Filed: 1983-12-18
Abstract: A composition comprised of I. 60 to 90% wt. of (a) from 70 to 95 weight percent of at least one of (i) one or more MgAl2O4 spinels heated at a temperature of about 600 DEG  C. to about 1700 DEG  C. and having less than 20% by weight of segregated phases of Al2O3 or MgO; (ii) MgAl(OH)5-nyXyn where y</=1; x=OH-, halogen, SO4=, NO3- carboxylate, halogenated carboxylate, H2PO4-, HPO4=, HCO3-, and the like which is prepared by coprecipitating a Mg and Al salt under controlled pH and Mg/Al ratios and which may also include segregated phases of AlO(OH), Mg(OH)2 and/or Al(OH)3 following pH adjustment; (iii) intermediates of (1) and (2) prepared by partial calcination of (2) at temperatures >/=300 DEG  C. but </=600 DEG  C.; (b) and from 5 to 30 weight percent of an aluminum, ammonium or alkali metal phosphate, polyphosphate, acid phosphates or their hydrates or a mixture of aluminum hydroxide or aluminum oxyhydroxide and phosphoric acid; and II. from 10 to 35 weight percent water; III. from 0 to 5 weight percent of modifiers selected from the group consisting of fumed Al2O3, glycerine, activated alumina, polyvinyl alcohol, MgO, Mg(OH)2 or mixtures of two or more thereof. Suitable for use in bonding particulate and/or shaped objects such as brick mortar, ramming compound, brick binder or the like.
Patent FI-863973-A0 (FI)
Inventor: REQUENA VICENTE CALZADO
IPC: A41H43/00
Filed: 1986-10-01
Abstract: Method and device for completing the automatical matching of panels to be cut in patterned fabrics to ensure that the design for each one of the panels to be cut is in its correct position. After defining a series of matching points on each of the patterns and recording as digital data in a memory the matching relationships for each one of these points are defined and stored as matching information in the memory, the matching itself is carried out using a TV-camera (12) installed on the cutting machine (11), capturing images from any point of the fabrics being spread in connection with a digital image processing unit which, by processing the images captured, fix the real position of the design on the fabrics. Matching device, integrated marking and a cutting system are connected in such a way to process the image information with the predicted matching relations to generate an adjustment to the position initially assigned to each panel - in both directions and in orientation - and guarantee a perfect cut of the panels.
Patent FI-870333-A0 (FI)
Inventor: COLLIENNE FRANZ-JOSEPH
IPC: B61F5/30
Filed: 1987-01-26
Abstract: A suspension arrangement for rail vehicles, including at least one pair of superimposed elastomeric shock absorbers, including a first shock absorber disposed between a first mandrel and a first bell-shaped member, and a second shock absorber disposed between a second mandrel and a second bell-shaped member. The first bell-shaped member and the second mandrel are disposed between the two shock absorbers and are interconnected in such a way that they can carry out not only a movement in the main direction of shock absorption, but also a pendulum movement about any axis disposed transverse to this main direction of shock absorption.
Patent FI-873883-A0 (FI)
Inventor: CLAAR T DENNIS
IPC: C04B38/08
Filed: 1987-09-08
Abstract: A method of producing a composite comprising a self-supporting polycrystalline material obtained by oxidation reaction of a molten parent metal (2) with a vapor-phase oxidant comprising infiltrating a filler (3) exhibiting inter-particle pore volume with a parent metal (2) under conditions which control the respective rates of said metal infiltration and said oxidation reaction.
Patent FI-901132-A0 (FI)
Inventor: CROONENBROCK RAIMUND
IPC: F23C9/00
Filed: 1990-03-06
Abstract: A fluidized bed combustion system that can be operated or controlled under pressure is provided. To eliminate the erosion or abrasion to which heat exchangers located in a fluidized bed combustion chamber are subjected due to the flue dust contained in the flue gas, no thermal withdrawal or exchange takes place in the combustion chamber of the inventive fluidized bed combustion system, although the reaction conditions remain the same. At least one controllable line for returning to the combustion chamber part of the flue gas, if necessary cooled by heat exchangers variously arranged outside the combustion chamber, branches off from the flue gas line downstream of a dust separator that is disposed in the flue gas line downstream of the combustion chamber. The main area of application is the production of electrical energy and heat for the generation of steam, as process heat, or as heat for a remote site, by means of a fluidized bed combustion system that can be operated or controlled under pressure.
Patent FI-901632-A0 (FI)
Inventor: LAAKSO JUKKA
IPC: C08L101/00
Filed: 1990-03-30
Abstract: PCT No. PCT/FI91/00082 Sec. 371 Date Jan. 30, 1992 Sec. 102(e) Date Jan. 30, 1992 PCT Filed Mar. 27, 1991 PCT Pub. No. WO91/15859 PCT Pub. Date Oct. 17, 1991.The invention relates to a method for preparing a conductive polymer product by doping a conductor polymer. The conductor polymer or a mixture of the conductor polymer and a matrix polymer is in a molten state brought into contact with a doping agent, whereafter the mixture is treated into a product.
Patent FI-905055-A0 (FI)
Inventor: STERNBERG NAT LEON
IPC: C12N1/21
Filed: 1990-10-15
Abstract: A P1 bacteriophage cloning system has been designed so that DNA fragments as large as 95 kb can be cloned and amplification of these fragments can be controlled. An in vitro P1 bacteriophage packaging process was developed. Novel vectors, novel lysogenic bacterial strains, and novel Cre<+> gram negative bacterial strains were engineered for use with this system.
Patent FI-914852-A0 (FI)
Inventor: STRAESSLE MARCEL
IPC: E04B1/58
Filed: 1991-10-15
Abstract: PCT No. PCT/CH91/00039 Sec. 371 Date Sep. 23, 1991 Sec. 102(e) Date Sep. 23, 1991 PCT Filed Feb. 13, 1991 PCT Pub. No. WO91/12383 PCT Pub. Date Aug. 22, 1991.A connection element for a three-dimensional framework includes a bolt (6, 7, 8, 9) which by means of a sleeve insert (3) can be fastened rotatably to one end of a rod (11), as well as a sleeve (12) into the axial through-bore of which the bolt is partly inserted, to transmit, sliding axially, a rotary movement of the sleeve (12) to the bolt. The through-bore is only in the front part of the sleeve (12) so that it can transmit a rotary movement of the sleeve (12) to the bolt. At the rear part of the sleeve (12) the through-bore has a circumference which is larger than the circumference of the form-locking front part of the through-bore. The bolt is urged out of the sleeve (12) by a spring (13). The front end part (9) of the connection element can be fastened to a junction part (10) of the three-dimensional framework.
Patent FI-930221-A0 (FI)
Inventor: UHLMANN EUGEN
IPC: C07F9/24
Filed: 1993-01-20
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R<1> = H, a substituent or -P(=W)ZZ'; R<2> = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R<3>, R<4> = substituents; p = 1-100; q = 0-18; R<11> = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta  or a group of formula (ii);  alpha  = 1-11;  beta  = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R<2> and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha  or  beta  configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR<5>R<6>); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R<5>, R<6> = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
Patent FI-933453-A0 (FI)
Inventor: HOEKSTRA JELLE
IPC: H04B1/20
Filed: 1993-08-03
Abstract: Apparatuses (1,2,3) of an audio/video system convey user commands to one another via a serial control bus (4). The user commands convey key activations on a remote handset (18a), whose keys include both "normal" keys such as "mute/unmute", and "repeat" keys such as "volume up" and "volume down". To convey a repeat key activation, a first control means (12) within one apparatus addresses a key activation message to a second control means (32) within another apparatus. The second control means (32) synthesises locally a repetitive series of user commands, until a key release message is received. The need for repetitive user command messages to be sent via the control bus is thereby eliminated, and the frequency of repetition can be defined locally to give consistent response to user commands. The second control means (32) can also implement a de-bouncing function, disregarding duplicate user command messages sent by a third apparatus (2) which also responds to the handset (18a). <IMAGE>
Patent FI-935093-A0 (FI)
Inventor: PARKIN ADRIAN
IPC: A61M5/32
Filed: 1993-11-17
Abstract: A multi-diameter hypodermic needle, including a thin walled tubing with at least two sections having different internal diameters, is used to inject a X-ray contrast fluid in a rapid manner such that a subsequent image of the injected area evinces enhanced contrast characteristics.
Patent FI-941268-A0 (FI)
Inventor: HOTTINEN ARI
IPC: H04W36/30
Filed: 1994-03-17
Abstract: PCT No. PCT/FI95/00141 Sec. 371 Date Apr. 8, 1996 Sec. 102(e) Date Apr. 8, 1996 PCT Filed Mar. 16, 1995 PCT Pub. No. WO95/25365 PCT Pub. Date Sep. 21, 1995A receiver, and a method for estimating received power in a cellular radio system having in each cell at least one base station communicating with mobile stations within its coverage area. The mobile stations measure strength of the signal received from a base station, and report the measurement results to that base station. To improve power adjustment, a model describing the dynamic behavior of the signal is created for the received power on each connection. The model is utilized for power adjustment, as well as for making handover decisions.
Patent FI-941677-A0 (FI)
Inventor: TOURNIER HERVE
IPC: A61B5/055
Filed: 1994-04-12
Abstract: Magnetite particles suitable for injection into the blood stream of patients having enhanced resistance against agglomeration and uptake by the RES of the liver and spleen. The particles essentially consist of an iron oxide core and a phosphoric acid mono alkyl or alkenyl ester or glycerophospholipid/surfactant three dimensional shell surrounding the core. The core and the monoester or a micellar glycerophospholipid form an urchin-like structure which is further interlaced or intertwined with a non-ionic surfactant to produce a protective three dimensional shell which renders particles almost undetectable by the macrophages. Particles prepared according to the invention are kept in the blood circulation for long periods and represent excellent long lasting blood pool agents. Key components in the shell are (a) a polybasic mineral-organic species such as glycero phosphatidic acid in micellar form and (b) a block copolymer having successive hydrophilic and hydrophobic segments.
Patent FI-943135-A0 (FI)
Inventor: RASMUSSEN HANS
IPC: A01K5/02
Filed: 1994-06-30
Abstract: PCT No. PCT/DK93/00008 Sec. 371 Date Aug. 22, 1994 Sec. 102(e) Date Aug. 22, 1994 PCT Filed Aug. 1, 1993 PCT Pub. No. WO93/13652 PCT Pub. Date Jul. 22, 1993.A feeding device for feeding animals, such as pigs or hogs, includes a tubular feed reservoir (16) and a feed discharge tube 27 having a feed discharge opening at its lower end (17) above a base member (10) defining a feed support surface (12). Troughs (11) may be arranged adjacent to the feed support surface (12), and the bottom surfaces (13) of the troughs are located on a lower level than the feed support surface (12). The feed reservoir (16) is suspended at its upper part in a pendulum-like manner and transverse movement of the reservoir is restricted by an encircling ring member (18). Animals being fed may push the lower end of the feed discharge tube (27) so that the lower end thereof is moved transversely. The lower length (31) of the feed discharge tube (27) is elastically flexible such that it may be flexed by larger pigs or animals, whereby the lower end of the feed discharge tube (27) may be moved further relative to the base member (10). Thus, the discharge rate of feed adapts itself to the size of the animals being fed.
Patent FI-943191-A0 (FI)
Inventor: LINNONMAA PEKKA
IPC: B05D3/00
Filed: 1994-07-01
Abstract: The present invention relates to a spray-coating method and apparatus. According to the method, a coating paste aerosol is sprayed onto a moving paper web (1) in an at least partially enclosed space (19). According to the invention, a coating paste flow (18) for collecting the excess aerosol from the spraying of the coating paste is provided on at least one inner wall (6) of said enclosed space (19). <MATH>
Patent FI-952681-A0 (FI)
Inventor: SULLIVAN JOANNE
IPC: A21D13/08
Filed: 1995-06-01
Abstract: Flaky pie shells that maintain their structural integrity even when filled with high moisture fillings contain fats bearing short C2 to C4 acid residues and long, saturated C16 to C22 fatty acid residues. One preferred embodiment contains fats bearing butyric acid residues and residues of fatty acids derived from fully hydrogenated oils containing at least about 75% stearic acid such as hydrogenated soybean oil or hydrogenated canola. Another preferred embodiment contains fats bearing the same complement of saturated long residues, but the short residues are derived from acetic and propionic acids. These fats are low in calories and low in palmitic acid and trans unsaturated acid residues. Pie shells made with the fats are tender and exhibit improved cohesiveness and mechanical strength during shipping, handling and storage.
Patent FI-962710-A0 (FI)
Inventor: HYUN CHUNG
IPC: H02K99/00
Filed: 1996-07-01
Abstract: The present invention relates to an electrical apparatus comprising a primary winding which produces a traveling magnetic field in addition to an alternating field and a secondary winding disposed so as to be interlinked to the alternating field and the traveling magnetic field set up by the primary winding. The primary winding produces the traveling magnetic field in addition to the alternating field by applying an intermittent direct current or an alternating current. The secondary winding is disposed so as to be interlinked to the alternating field and the traveling magnetic field set up by the primary winding for inducing an electromotive force. A core comprising an annular core portion and a cylindrical core portion is disposed in the hollow area of the annular core portion such that these core portions are magnetically coupled. A plurality of slots each extending axial and radial between the core portions (10A,10B) is spaced uniformly in the peripheral direction. The primary windings comprise phase windings and the secondary windings comprise phase windings, whereby the primary windings and secondary windings are disposed into the slots.
Patent FI-972683-A0 (FI)
Inventor: TAYLORSON CHRISTOPHER JOHN
IPC: A61K47/48
Filed: 1997-06-19
Abstract: PCT No. PCT/GB95/02991 Sec. 371 Date Jun. 23, 1997 Sec. 102(e) Date Jun. 23, 1997 PCT Filed Dec. 21, 1995 PCT Pub. No. WO96/20011 PCT Pub. Date Jul. 4, 1996A two component system for therapeutic treatment of a host, having a first component comprising a targeting moiety capable of binding with a tumour associated antigen, linked to a mutated enzyme capable of converting a prodrug into an antineoplastic drug, and a second component comprising a prodrug convertible under the influence of the mutated enzyme to the antineoplastic drug. The mutated enzyme is a mutated form of a natural host enzyme which recognizes its natural substrate by an ion pair interaction with the substrate, wherein the mutated enzyme and prodrug have structures such that the polarity of the mutated enzyme/prodrug ion pair interaction is reversed relative to the natural host enzyme/natural substrate ion pair interaction. The first component is substantially non-immunogenic in the host and the prodrug second component is not significantly convertible into antineoplastic drug in the host by natural unmutated host enzyme.
Patent IL-58193-A0 (IL)
Title: 3,4,5-trihydroxypiperidine derivatives their production and pharmaceutical compositions containing them
IPC: A61P9/12
Filed: 1979-09-06
Abstract: The invention relates to 3,4,5-trihydroxypiperidines, processes for their producion, compositions containing them and methods for the use of said 3,4,5-trihydroxypiperidines and compositions containing them. The compounds and compositions of the invention are useful, inter alia, for their saccharase inhibiting activity in warm-blooded animals as well as their ability to improve feed utilization in warm-blooded and cold-blooded animals.
Patent IL-74442-A0 (IL)
Title: Test device and method for the detection of a component of a liquid sample
IPC: G01N33/52
Filed: 1985-02-26
Abstract: In a test strip for the detection of a component in a liquid sample, the strip comprising a support layer, a microporous polymer layer and a reagent for the detection of the component to be determined, the improvement wherein the microporous polymer layer is a membrane which has an asymmetric pore structure with the narrower pores being on the side to which the sample is applied, and the support layer is macroscopically smooth. The porous membrane is produced by coagulation from solution.
Patent IL-75064-A0 (IL)
Title: Covalently-modified bacterial polysaccharides,stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers,and methods of preparing such polysaccharides and conjugates and of confirming covalency
IPC: C07K17/10
Filed: 1985-05-01
Abstract: Covalently modified bacterial polysaccharides and proteins; covalent conjugates of such polysaccharides linked by a bigeneric spacer, which permits proof of covalency and facilitates purification of conjugated materials, with immunogenic bacterial membrane or other proteins, which conjugates are useful components of bacterial vaccines; and methods of preparing such polysaccharides, proteins and conjugates and of confirming the covalency of the linkage between polysaccharides and proteins.
Patent IL-81302-A0 (IL)
Title: Pyrrolo(1,2-a)(4,1)benzoxazepine derivatives
IPC: A61P1/00
Filed: 1987-01-19
Abstract: Disclosed are the compounds of the formula    <IMAGE>  (I)  wherein n represents the integer 1,2,3 or 4; R1 represents hydrogen, lower alkyl, halogen, trifluoromethyl, hydroxy or lower alkoxy; R2 represents hydrogen or lower alkyl; R3 represents hydrogen, lower alkyl or halogen; R4 represents amino, lower alkylamino, di-lower alkylamino, morpholino, N-lower alkyl or N-aryl piperazino, pyrrolidino, piperidino or substituted piperidino selected from <IMAGE>   <IMAGE>  +TR  <IMAGE>  in which R5 represents hydrogen, halogen or lower alkyl; and pharmaceutically acceptable salts thereof; which are useful in mammals as calmodulin antagonists for the treatments of gastrointestinal disorders.
Patent IL-82553-A0 (IL)
Title: Distamycin a analogs,their preparation and pharmaceutical compositions containing them
IPC: A61P35/00
Filed: 1987-05-18
Abstract: Distamycin A analogs of the following formula (I): <CHEM>  wherein  n is 2, 3 or 4;  A is a divalent radical chosen from <CHEM> and -Het-, wherein Het is a pentatomic or hexatomic heteromonocyclic ring, except pyrrole, the said radical being unsubstituted or substituted by one or more substituents chosen from C1-C6 alkyl, C1-C6 alkoxy, cyano and trifluoromethyl;  and either one of R1 and R2 is hydrogen and the other is a) a group <CHEM> in which R3 is C1-C6 alkyl unsubstituted or substituted by halogen atoms; phenyl; or cyclohexyl; or b) a group -CO-(CH2)m-R4 in which m is zero, 1, 2 or 3 and R4 is hydrogen, halogen, hydroxy, aziridinyl or oxiranyl; or R1 and R2 are the same and they are both hydrogen or both a C1-C6 alkyl group unsubstituted or substituted by halogen, hydroxy or C1-C6 alkoxy; and the pharmaceutically acceptable salts thereof; are antitumor and antiviral agents.
Patent IL-84084-A0 (IL)
Title: Quarternized nitrogen containing compounds
IPC: A61Q5/12
Filed: 1987-10-04
Abstract: The invention relates primarily to quaternized compounds having formula (I), wherein m is an integer having a value of from 1 to 4; R is alkylene having from 3 to 8 carbon atoms and is optionally substituted with C1 to C4 alkyl; R1, R2 and R3 are each independently selected from the group of alkyl, alkyleneoxyalkyl, alkyleneoxyalkenyl, alkylhydroxy, aryl, aralkenyl, aralkyl, alkaryl, alkyleneamidoalkyl, alkylenecarbamoylalkyl, arylcarbamoylalkyl and arylamidoalkyl radicals, said groups each having from 1 to 30 carbon atoms and at least one of R1, R2 and R3 is a radical having from 8 to 30 carbon atoms, except that R2 and R3 with the quaternized nitrogen can form a 5 to 14 membered heterocyclic ring having from 1 to 2 heteroatoms selected from the group of oxygen, nitrogen and sulfur, in which case R1 can also represent a double bond in the quaternized heterocyclic ring.
Patent IL-87250-A0 (IL)
Title: Alpha-unsaturated amines,their production and use
IPC: C07D277/42
Filed: 1988-07-28
Abstract: α-Unsaturated amines of the formula:wherein X¹ and X² are such that one is an electron-attracting group with the other being a hydrogen atom or an electron-attracting group; R¹ is a group attached through a nitrogen atom; R² is a hydrogen atom or a group attached through a carbon, nitrogen or oxygen atom; n is an integer equal to 0, 1 or 2; A is a heterocyclic group or a cyclic hydrocarbon group, and salts thereof and their agrochemical use as insecticidal and/or miticidal agents are described.
Patent IL-89257-A0 (IL)
Title: Antiulcer pyrimidine derivatives
IPC: A61K31/505
Filed: 1989-02-10
Abstract: 8-(2-Pyrimidylsulfinyl)quinolines of general formula I <CHEM> or a pharmaceutically acceptable acid addition salt thereof wherein Q is hydrogen, fluoro, chloro, nitro, amino, trifluoromethyl, alkanoylamino of two to four carbon atoms, alkoxy of one to five carbon atoms, alkyl of one to five carbon atoms or dialkylamino said alkyl having one to four carbon atoms; X is hydrogen, alkyl of one to five carbon atoms or alkoxy of one to five carbon atoms; Y is hydrogen, fluoro, chloro, bromo, alkoxy of one to five carbon atoms or alkyl of one to five carbon atoms; Z is hydrogen, alkyl of one to five carbon atoms, alkoxy of one to five carbon atoms, phenoxy, benzyloxy, cycloalkyloxy of five to seven carbon atoms, amino, alkylamino having one to four carbon atoms, dialkylamino said alkyl having one to four carbon atoms, anilino, N-alkylanilino said alkyl having one to four carbon atoms, benzylamino, N-alkylbenzylamino said alkyl having one to four carbon atoms, morpholino, piperidino or pyrrolidino; and n is 1, are inhibitors of the H<+>/K<+> ATPase system and are useful in the treatment of ulcers.